InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2025-07-03 | Gilbert Cisneros(D-CA31) | house | Sale | $1,001 - $15,000 |
No financial data available for DSKYF.
Company may not file with SEC or CIK is unresolved.
Citi sees Daiichi supply review as immaterial for AstraZeneca
Nuvation Bio (NUVB) Stock More Than Doubles Year-on-Year
5 Best Small-Cap Biotech Stocks According to Hedge Funds
Dana-Farber Cancer Institute Study Demonstrates Predictive Value of Ignite Proteomics’ RPPA Platform for T-DXd (Enhertu®) Therapy in Metastatic Breast Cancer Patients
Merck’s Priority Review Cancer Drug Adds To Undervalued Growth Story
Interna Therapeutics Announces Research Collaboration with Daiichi Sankyo to Advance MNM-Based Targeted Delivery Technologies
Wayfinder Biosciences Advances Collaboration with Daiichi Sankyo on Key Neurodegeneration Target to Second Phase
Suntory buying Daiichi Sankyo unit for $1.3B, Nikkei reports
MRK, Daiichi's BLA for ADC Drug Gets FDA Priority Tag in Lung Cancer
Nuvation Bio gains global rights to brain cancer therapy from Daiichi Sankyo
Daiichi Sankyo: Hit On Multiple Fronts, But Shares Look Undervalued
Astra wins FDA priority review for Daiichi’s Datroway; denied approval for lupus therapy